ad

Virginia Sturm, PhD

Assistant Professor

Virginia Sturm, PhD, is an Assistant Professor at the UCSF Memory and Aging Center. After undergraduate work at Georgetown University, she received her PhD degree in clinical psychology at the University of California, Berkeley and subsequently completed her clinical internship and postdoctoral fellowship at UCSF. Her research centers on laboratory measurement of emotion and social behavior in patients with neurodegenerative disease.

Dr. Sturm directs the Clinical Affective Neuroscience (CAN) Laboratory located in the UCSF Memory and Aging Center and affiliated with the UCSF Center for Psychophysiology and Behavior (CPB).

Glossary of Medical Terms

This list defines many of the words or terms you will hear when discussing neurodegenerative disease.

  • agnosia: A loss of the ability to recognize objects, persons, sounds, shapes or smells without injury to the primary sensory organ or memory loss
  • agrammatism: The presence of grammatical errors in speech, such as the omission or incorrect usage of articles (“cow jumped over moon”), prepositions (“dog walk bridge”) or verbs (“cat eated mouse”).

Anna M. Karydas

Genetics and Specimens Project Manager

Anna Karydas joined the Memory and Aging Center in 2005 to support research activities investigating genetic causes of neurodegenerative diseases. She manages our laboratory specimens, genetic samples and genetic collaborations.

Frequently Asked Questions (FAQ)

Before you or your loved one join a research trial or study, your doctor should talk to you about what it's like to be in a trial and describe the pros and cons of participating. If you are interested, someone from the clinical trial staff will explain the details of the study, risks and benefits, and your rights as a participant, including your right to withdraw from the study at any point. Once all your questions have been answered, they will ask you to sign an informed consent to participate.

Choosing to participate in a clinical trial or research study is an important personal decision. The following frequently asked questions (FAQ) provide detailed information about clinical trials and were modified from the NIH Clinical Trials website, the UCSF Human Subjects Protection Program Website and the National Institute on Aging Alzheimer’s Disease website.

Syndicate content